Market News

Swarthmore Group Has Cut Medtronic Plc (MDT) Stake as Stock Price Rose; Gmt Capital Increased Its Dynavax Technologies (DVAX) Position by $1.10 Million

Thomas E. Claugus increased its stake in Dynavax Technologies Corp (DVAX) by 1.74% based on its latest 2017Q3 regulatory filing with the SEC. Gmt Capital Corp bought 52,300 shares as the company’s stock rose 37.50% with the market. The hedge fund run by Thomas E. Claugus held 3.06 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $65.74 million, up from 3.01M at the end of the previous reported quarter. Gmt Capital Corp who had been investing in Dynavax Technologies Corp for a number of months, seems to be bullish on the $1.05B market cap company. The stock increased 0.58% or $0.1 during the last trading session, reaching $17.35. About 1.13M shares traded. Dynavax Technologies Corporation (NASDAQ:DVAX) has declined 63.84% since February 21, 2017 and is downtrending. It has underperformed by 80.54% the S&P500.

Swarthmore Group Inc decreased its stake in Medtronic Plc (MDT) by 16.61% based on its latest 2017Q3 regulatory filing with the SEC. Swarthmore Group Inc sold 18,575 shares as the company’s stock rose 5.51% with the market. The institutional investor held 93,250 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q3, valued at $7.25M, down from 111,825 at the end of the previous reported quarter. Swarthmore Group Inc who had been investing in Medtronic Plc for a number of months, seems to be less bullish one the $109.43 billion market cap company. The stock decreased 0.93% or $0.76 during the last trading session, reaching $80.85. About 4.54 million shares traded. Medtronic plc (NYSE:MDT) has risen 4.04% since February 21, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

Investors sentiment increased to 1.12 in Q3 2017. Its up 0.22, from 0.9 in 2017Q2. It increased, as 73 investors sold MDT shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. Union Bancshares, a Virginia-based fund reported 6,340 shares. Orrstown Finance Serv Inc owns 11,115 shares. Korea Investment Corp has invested 0.46% of its portfolio in Medtronic plc (NYSE:MDT). Carlson Management invested in 3,023 shares. Bluecrest Capital Mgmt Ltd, Guernsey-based fund reported 128,623 shares. Bb&T Ltd Llc accumulated 232,416 shares. Hanson And Doremus Management reported 15,138 shares stake. Apg Asset Mngmt Nv has 0.06% invested in Medtronic plc (NYSE:MDT). Moreover, Winslow Evans Crocker has 0.04% invested in Medtronic plc (NYSE:MDT) for 1,656 shares. Marble Harbor Inv Counsel Ltd, Massachusetts-based fund reported 16,108 shares. Scotia accumulated 0.1% or 89,417 shares. Burt Wealth accumulated 112 shares or 0.01% of the stock. Moreover, Pinnacle Ptnrs has 0.32% invested in Medtronic plc (NYSE:MDT). First Fincl Bank Of Omaha reported 0.61% in Medtronic plc (NYSE:MDT). Mitsubishi Ufj Securities Limited stated it has 260 shares.

Swarthmore Group Inc, which manages about $1.77B and $437.39 million US Long portfolio, upped its stake in Select Sector Spdr Tr (XLF) by 38,025 shares to 599,925 shares, valued at $15.51M in 2017Q3, according to the filing.

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 79 analyst reports since August 10, 2015 according to SRatingsIntel. The company was maintained on Monday, October 9 by Needham. BMO Capital Markets maintained the stock with “Outperform” rating in Wednesday, November 23 report. The rating was maintained by Needham on Tuesday, June 7 with “Buy”. The rating was maintained by Needham on Tuesday, November 21 with “Buy”. The rating was maintained by SunTrust on Monday, June 13 with “Buy”. The stock of Medtronic plc (NYSE:MDT) earned “Buy” rating by RBC Capital Markets on Friday, September 22. The firm has “Buy” rating given on Monday, July 10 by Wells Fargo. The firm has “Neutral” rating given on Tuesday, January 3 by Bank of America. RBC Capital Markets maintained Medtronic plc (NYSE:MDT) rating on Sunday, August 20. RBC Capital Markets has “Buy” rating and $90.0 target. UBS maintained it with “Buy” rating and $94 target in Friday, February 17 report.

Investors sentiment decreased to 2.06 in Q3 2017. Its down 0.27, from 2.33 in 2017Q2. It fall, as 13 investors sold DVAX shares while 19 reduced holdings. 25 funds opened positions while 41 raised stakes. 41.91 million shares or 20.83% more from 34.68 million shares in 2017Q2 were reported. Moreover, Dekabank Deutsche Girozentrale has 0% invested in Dynavax Technologies Corporation (NASDAQ:DVAX). The New York-based Jpmorgan Chase Company has invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). The California-based First Republic Invest Incorporated has invested 0.02% in Dynavax Technologies Corporation (NASDAQ:DVAX). Massachusetts-based Geode Ltd Liability Corp has invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). Cubist Systematic Strategies Ltd Liability Com holds 0.01% or 5,404 shares. American Group Inc holds 0% or 40,399 shares. C World Wide Hldgs A S invested in 0.25% or 823,825 shares. Jane Street Group Limited Co owns 21,008 shares. Glenhill Advsrs Ltd Liability Corporation, New York-based fund reported 277,288 shares. Howard Hughes Medical Institute holds 0.11% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX) for 21,355 shares. Pennsylvania-based Vanguard Grp has invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). Bnp Paribas Arbitrage Sa, a New York-based fund reported 6,139 shares. Rhumbline Advisers accumulated 0% or 70,673 shares. Winch Advisory Limited Com holds 0.01% or 350 shares. Susquehanna Intll Limited Liability Partnership reported 0% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX).

Among 6 analysts covering Dynavax Technologies (NASDAQ:DVAX), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Dynavax Technologies had 22 analyst reports since August 12, 2015 according to SRatingsIntel. Zacks upgraded the stock to “Hold” rating in Wednesday, August 12 report. The rating was maintained by J.P. Morgan with “Hold” on Friday, July 21. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, September 27 report. William Blair maintained the shares of DVAX in report on Friday, July 21 with “Buy” rating. On Thursday, April 28 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. The firm has “Buy” rating given on Thursday, November 9 by Cantor Fitzgerald. Cowen & Co maintained the stock with “Buy” rating in Thursday, August 3 report. The stock of Dynavax Technologies Corporation (NASDAQ:DVAX) has “Buy” rating given on Monday, January 22 by RBC Capital Markets. The stock of Dynavax Technologies Corporation (NASDAQ:DVAX) earned “Buy” rating by RBC Capital Markets on Sunday, October 29. On Monday, July 31 the stock rating was upgraded by RBC Capital Markets to “Outperform”.

Since December 13, 2017, it had 0 insider buys, and 2 sales for $199,261 activity. COFFMAN ROBERT sold $141,750 worth of stock or 7,500 shares.

Gmt Capital Corp, which manages about $9.19B and $4.69 billion US Long portfolio, decreased its stake in Alico Inc (NASDAQ:ALCO) by 16,911 shares to 518,266 shares, valued at $17.70 million in 2017Q3, according to the filing. It also reduced its holding in Viad Corp (NYSE:VVI) by 214,000 shares in the quarter, leaving it with 1.06M shares, and cut its stake in Lam Research Corp (NASDAQ:LRCX).

Leave a Reply

Your email address will not be published. Required fields are marked *